Skip to main content
Caplight Logo









Pre Diagnostics AS

Pre Diagnostics AS

Private
OsloHealthcare & Life Scienceshttps://www.pre-diagnostics.com/

Last Round

Grant

Mar 5, 2025

Total Funding Raised

$4.13M

Company Overview

Pre Diagnostics AS is a biotechnology company that develops blood-based diagnostic tests for the early detection of Alzheimer's disease and other neurodegenerative conditions.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Medical Devices, Precision Medicine, Clinical Trials

Business Model

B2B

Customer Profile

Services & Consulting, Government Contracts

AI Layer

Non-AI

Keywords

Alzheimer's diagnosticsbiomarker discoveryintracellular immunoassayblood-based diagnosticsliquid biopsyneurodegenerative disease testingpatient stratificationclinical trial recruitmentbeta-amyloid testinganalytical laboratory servicesearly disease detectionbiotech out-licensingneurology research

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Pre Diagnostics AS Comparables

Compare Pre Diagnostics AS with similar companies based on industry and business-model similarity.

Pre Diagnostics AS comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
C2N Diagnostics
83%
ADmit Therapeutics
81%
Aptorum Group Limited
78%

Pre Diagnostics AS Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
GrantMar 5, 2025
GrantDec 1, 2018
SeedNov 13, 2015

Key People

Founding team and executive leadership

Erik Christensen

CMO COO

Executive Team

Line Solum Amundsen

COO & Laboratory Director

Executive Team

Pre Diagnostics AS Investors

Notable investors and investment history

Pre Diagnostics AS investors
InvestorRounds
Innovasjon NorgeSeed
European Union's Horizon 2020Grant

Market signals

Structured signals derived from secondary market and firmographic data.

  • Mar 5, 2025

    $8.34M grant received from Horizon Europe

  • Oct 29, 2024

    Monthly visitors grew 78% MoM, reaching 474.

Pre Diagnostics AS Filings

Explore SEC and related filing metadata, where available.

Pre Diagnostics AS filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Pre Diagnostics AS's valuation, stock price, and market status.

Is Pre Diagnostics AS a public or private company?

Pre Diagnostics AS is a private company.

What is the current stock price of Pre Diagnostics AS?

Pre Diagnostics AS is a private company with no public stock price. No recent secondary market data is available.

How much is Pre Diagnostics AS worth (valuation)?

Valuation information for Pre Diagnostics AS is not publicly available.

Can I buy Pre Diagnostics AS stock?

Pre Diagnostics AS shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was Pre Diagnostics AS's last funding round?

Pre Diagnostics AS's most recent funding round was Grant on March 5, 2025.

Who are the main investors in Pre Diagnostics AS?

Key investors in Pre Diagnostics AS include European Union (Horizon 2020).

Will Pre Diagnostics AS IPO soon?

No public IPO plans have been announced for Pre Diagnostics AS.

How can I track Pre Diagnostics AS secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Pre Diagnostics AS's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersOslo
Employee Range10
Year Founded2013
Last FundingMar 5, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?